![]() |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Friday, February 10, 2012
|
Head and Neck Cancer |
Targeted Therapy and Nasopharyngeal Cancer01/06/2009 |
Would targeted therapy (Cetuximab) be a consideration for an elderly person with stage IV nasophyarngeal cancer?
Cetuximab may be included in the treatment plan in patients who are elderly or who have poor performance status, either alone or in combination with other agents.
|
Panayiotis Savvides, MD Assistant Professor of Medicine Division of Hematology and Oncology Department of Medicine School of Medicine Case Western Reserve University |
|
|
Heather Hines, RN Medical Oncology Nurse School of Medicine Case Western Reserve University |
|